Pharma channel feed

Te­va and Al­ler­gan reach an­oth­er opi­oid set­tle­ment, this time for $54M with San Fran­cis­co

3 years ago
Law

En­do con­sid­ers bank­rupt­cy fil­ing as it feels the heat from thou­sands of opi­oid law­suits — re­port

3 years ago
Law

How in­ter­est in a sin­gle can­cer drug led to Ipsen's takeover of Epizyme

3 years ago
Deals

UCB adds re­al pa­tient voic­es from across arthri­tis con­di­tions in ‘Ad­van­tage Hers’ cam­paign

3 years ago
Marketing

Hori­zon Ther­a­peu­tics scores 'Ma­ma Du­ran­t' in cam­paign to raise aware­ness for rare eye dis­ease

3 years ago
Marketing

Cal­i­for­nia to man­u­fac­ture and pro­duce its own in­sulin as Con­gress de­bates $35 month­ly cap

3 years ago
Manufacturing

Mar­ket­ingRx roundup: Pfiz­er bows high-risk Covid treat­ment ads; Lil­ly drops first so­cial ads af­ter alope­cia ap­proval

3 years ago
Marketing

Rx-to-OTC switch­es: What FDA's new pro­posed rule means for phar­ma com­pa­nies

3 years ago
FDA+

More than Covid: Mod­er­na up­dates its look, preps cor­po­rate cam­paign as it builds broad­er mR­NA tech­nol­o­gy brand

3 years ago
Marketing

FDA lifts hold on Green­wich Life­Sciences as biotech will forge ahead with im­munother­a­py drug can­di­date

3 years ago
FDA+
Manufacturing

Ac­cess to methotrex­ate in lim­bo post-Roe — re­port

3 years ago

Am­gen's block­buster hope­ful Lumakras sees slow­er than ex­pect­ed sales in lat­est da­ta, an­a­lyst says

3 years ago

Strug­gling biotech sells its API man­u­fac­tur­ing arm to nar­row its fo­cus

3 years ago
Financing
Manufacturing

New York AG ac­cus­es Te­va of ly­ing over opi­oid cri­sis to evade le­gal ac­tion

3 years ago
Law

Emer­gent nets an­oth­er man­u­fac­tur­ing deal, this time for Ridge­back­'s Ebo­la treat­ment

3 years ago
Deals
Manufacturing

Con­gres­sion­al reps push FDA to adopt ‘clear, con­spic­u­ous and neu­tral’ rule for phar­ma drug ads

3 years ago
FDA+
Marketing

HRA Phar­ma seeks ap­proval for first-ever OTC birth con­trol pill in the US

3 years ago
FDA+

CBO projects Sen­ate drug pric­ing bill would cut the de­vel­op­ment of 10 drugs over 30 years

3 years ago
Law

Flori­da Gov. De­San­tis hints at su­ing FDA over stalled Cana­di­an drug im­port plan

3 years ago
FDA+

FDA says it won't al­low state-li­censed phar­ma­cists to pre­scribe Mer­ck­'s Lagevrio

3 years ago
Coronavirus

Hori­zon nabs FDA ex­pand­ed la­bel for gout med Krys­texxa

3 years ago
Marketing

Sinopharm mulls $1B buy­out of Chi­na-based DNA syn­the­sis com­pa­ny — re­port

3 years ago
Deals
China

An­oth­er In­di­an drug man­u­fac­tur­er hit with a Form 483 over re­cent ob­ser­va­tions

3 years ago
FDA+
Manufacturing

Ger­man chem­i­cals com­pa­ny to ex­pand its reach in­to mR­NA in­gre­di­ent pro­duc­tion

3 years ago
Manufacturing
First page Previous page 188189190191192193194 Next page Last page
A service from the Financial Times